AlphaTON stock soars 200% after pioneering digital asset oncology initiative
Investing.com - JPMorgan has reiterated its Overweight rating and CHF4,200.00 price target on Givaudan SA (SIX:GIVN) following the company’s Summer Conference in Zurich where it presented its 2030 strategy.
The Swiss flavor and fragrance company outlined a more ambitious organic sales growth range of 4-6% and maintained its target of achieving greater than 12% free cash flow margin on average. Givaudan also raised its EBITDA margin guidance to 22-25%, up from its previous 22-24% range.
For fiscal year 2025, Givaudan provided guidance of approximately 5.5% organic sales growth, in line with consensus estimates, while noting tougher comparisons in the third quarter than the fourth quarter.
The company identified several growth accelerators, including the increasing importance of Local & Regional customers, expanding Emerging Markets sales, and market share gains. Future growth focus areas include pet food, health and wellbeing, and beauty ingredients, alongside its core flavor and fragrance business.
Mergers and acquisitions remain a strategic priority for Givaudan, particularly to extend its reach with Local & Regional customers and in beauty and Taste & Wellbeing adjacencies, as the company’s Net Debt to EBITDA ratio approaches 2x.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.